ETrade Capital Management’s bluebird bio BLUE Stock Holding History

ETrade Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$548K	Buy	+784	New	+$611K	0.01%	539

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

ETrade Capital Management's BLUE Position: Q3 2020 in Review

ETrade Capital Management opened a new position in bluebird bio (BLUE) in Q3 2020: 784 shares worth $548K. The stake represents 0.01% of the portfolio and ranks #539 among its holdings.

275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

ETrade Capital Management held 784 shares of bluebird bio worth $548K as of Q3 2020.
bluebird bio was a new ETrade Capital Management position in Q3 2020.
bluebird bio made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #539 holding.
275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.